Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neural Galaxy has developed a proprietary system that enables individualized mapping of the human brain’s functional sectors using MRI and AI algorithms. Its POINT Therapy device provides non-invasive, personalized interventions by reading, decoding, and writing neural signals to repair abnormal functions. Clinical trials have shown high effectiveness rates—for example, 86% efficacy in depression—with positive results also reported for autism, stroke recovery, aphasia, Parkinson’s disease, and more. The technology is already deployed at several top Chinese hospitals with thousands of cases analyzed or treated.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neural Galaxy.